
PLx Pharma PLXP
Quarterly report 2022-Q3
added 05-16-2026
PLx Pharma Total Inventories 2011-2026 | PLXP
Annual Total Inventories PLx Pharma
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2.46 M | 143 K | - | - | 246 K | 117 K | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.46 M | 117 K | 741 K |
Quarterly Total Inventories PLx Pharma
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 3.18 M | 3.88 M | 3.84 M | 2.46 M | 2.19 M | 1.26 M | - | 143 K | 143 K | 100 K | - | - | - | - | - | - | 246 K | 246 K | 246 K | 246 K | 373 K | 395 K | 246 K | 117 K | 117 K | 117 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.88 M | 100 K | 1.03 M |
Total Inventories of other stocks in the Drug manufacturers industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Endo International plc
ENDP
|
246 M | - | - | $ 28.9 M | ||
|
Evoke Pharma
EVOK
|
445 K | - | - | $ 36.6 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
6.23 M | $ 5.48 | -4.2 % | $ 81.4 M | ||
|
AcelRx Pharmaceuticals
ACRX
|
1.18 M | - | 7.5 % | $ 6.35 M | ||
|
DURECT Corporation
DRRX
|
106 K | - | - | $ 50.1 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
1.24 M | - | 0.86 % | $ 117 M | ||
|
Aerie Pharmaceuticals
AERI
|
40.4 M | - | - | $ 754 M | ||
|
Agile Therapeutics
AGRX
|
2.74 M | - | 10.11 % | $ 58.2 M | ||
|
Alimera Sciences
ALIM
|
1.88 M | - | - | $ 142 M | ||
|
Cronos Group
CRON
|
46.8 M | $ 2.74 | -1.79 % | $ 1.05 B | ||
|
Athenex
ATNX
|
42.7 M | - | -23.39 % | $ 1.76 M | ||
|
Harrow Health
HROW
|
13.5 M | $ 35.9 | 7.29 % | $ 1.32 B | ||
|
Avadel Pharmaceuticals plc
AVDL
|
20.3 M | - | - | $ 2.06 B | ||
|
Catalent
CTLT
|
574 M | - | - | $ 11.5 B | ||
|
Organogenesis Holdings
ORGO
|
29.6 M | $ 2.47 | -0.4 % | $ 313 M | ||
|
Eagle Pharmaceuticals
EGRX
|
47.8 M | - | -39.89 % | $ 27.7 M | ||
|
Canopy Growth Corporation
CGC
|
96.4 M | $ 1.01 | -0.98 % | $ 109 M | ||
|
Pacira BioSciences
PCRX
|
125 M | $ 23.42 | 0.9 % | $ 1.08 B | ||
|
Sonoma Pharmaceuticals
SNOA
|
2.92 M | $ 1.09 | -1.8 % | $ 1.35 M | ||
|
Jupiter Wellness
JUPW
|
949 K | - | - | $ 33.6 M | ||
|
Lannett Company
LCI
|
95.2 M | - | 1.15 % | $ 7.11 M | ||
|
Tilray
TLRY
|
201 M | $ 5.02 | -2.9 % | $ 3.1 B | ||
|
Evolus
EOLS
|
27 M | $ 6.72 | 0.3 % | $ 433 M | ||
|
Emergent BioSolutions
EBS
|
343 M | $ 8.24 | 3.65 % | $ 441 M | ||
|
Veru
VERU
|
4.14 M | $ 2.95 | -4.84 % | $ 43.2 M | ||
|
cbdMD
YCBD
|
2.95 M | $ 0.69 | -3.22 % | $ 2.78 M | ||
|
Assertio Holdings
ASRT
|
24.1 M | $ 23.48 | 0.09 % | $ 150 M | ||
|
ProPhase Labs
PRPH
|
70 K | - | - | $ 5.07 M | ||
|
Radius Health
RDUS
|
11.4 M | - | - | $ 1.42 B | ||
|
Bausch Health Companies
BHC
|
1.63 B | $ 5.15 | -0.39 % | $ 1.91 B | ||
|
PetIQ
PETQ
|
159 M | - | 1.64 % | $ 400 M | ||
|
Recro Pharma
REPH
|
10.3 M | - | -4.76 % | $ 65.3 M | ||
|
OptiNose
OPTN
|
11.5 M | - | - | $ 1.08 B | ||
|
SCYNEXIS
SCYX
|
899 K | $ 4.15 | -4.82 % | $ 207 M | ||
|
Viatris
VTRS
|
4 B | $ 15.77 | -2.65 % | $ 18.4 B | ||
|
Zomedica Corp.
ZOM
|
5.54 M | - | -0.21 % | $ 98 M | ||
|
Rockwell Medical
RMTI
|
3.42 M | $ 0.67 | -2.74 % | $ 24.1 M | ||
|
China Pharma Holdings
CPHI
|
1.62 M | $ 0.77 | 8.02 % | $ 3.3 M | ||
|
TherapeuticsMD
TXMD
|
7.99 M | $ 1.86 | -1.06 % | $ 21.5 M |